Point-of-Care Testing

Quest Diagnostics offers suite of services for transplant patients and living donors

The offerings of the Quest Advanced Specialized Transplant Services suite include access to Quest’s national network of service centers and mobile phlebotomists for both recipients and living donors in the 48 contiguous U.S. states.

March 23, 2023

CND Life Sciences, Beth Israel sign agreement on skin-based testing technology for neurodegenerative diseases

The agreement with Beth Israel Deaconess Medical Center aims to solidify important technology for CND’s Syn-One Test, a skin-based test that aids the diagnosis of synucleinopathies, a family of neurodegenerative disorders.

March 22, 2023

Patients prefer immediate test results, even when the news is bad

In a recent survey, patients overwhelmingly preferred receiving their test results immediately, even if their provider had not yet reviewed them.

March 21, 2023

LumiraDx Q4 revenues drop 65% on lower COVID-19 testing

The firm recorded an accounting impairment in Q4 for excess manufacturing and inventory related to the scale-up during peak COVID-19 testing demand and the decision to pause commercialization of its Amira COVID-19 test.

March 21, 2023

Cue Health receives FDA emergency use authorization for molecular mpox test

The test demonstrated high accuracy in clinical trials, achieving 100% concordance with the Center for Disease Control and Prevention’s (CDC's) mpox test on the samples tested, Cue Health said.

March 20, 2023

Researchers in Spain demonstrate HCV RNA detection, genotyping using dried blood spot samples

The research shows the potential of using dried blood spot samples for determining cure rates and differentiating between reinfection and relapse after antiviral treatment in people who inject drugs.

March 20, 2023

Most Popular

Quest launches long-COVID testing panels for consumers

Ohio, Kentucky doctors convicted in scheme to bill Medicaid for millions of dollars in unnecessary urinalysis testing

RNA-seq analysis links protein to spread of pancreatic cancer, reveals potential drug target

LumiraDx Q4 revenues drop 65% on lower COVID-19 testing

Patients prefer immediate test results, even when the news is bad

Point-of-care test developer Proxim Diagnostics obtains strategic investment from BioMérieux

Cue Health Q4 revenues decline 24% as firm expands, diversifies POC test menu

The company’s revenues have come predominantly from its COVID-19 testing product, but it is "executing well" on its strategy of expanding the test menu, CEO Ayub Khattak said.

March 16, 2023

Amplified Sciences developing dye-based tests for early detection of pancreatic cancer

Tests under development by the Purdue Research Foundation-affiliated startup use dyes to identify the potential for malignancy in fluid extracted from a cyst on the pancreas.

March 15, 2023

Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition

Chembio “faces ongoing operational and financial challenges” if it remains an independent company, its CEO wrote in a letter to stockholders.

March 15, 2023

Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test

Glow-in-the-dark proteins, developed from the luciferase found in bioluminescent creatures, may make viral disease diagnosis quicker and easier, according to the researchers.

March 15, 2023

Cue Health launches at-home diagnostic tests, expands test-to-treat service

March 13, 2023

DnaNudge, Mylab to develop MDx tests for diabetic foot infections, other health conditions

DnaNudge anticipates that its multiplex tests will enable health teams to identify the specific microbiological organisms responsible for each foot infection, providing antimicrobial resistance results in just over an hour.

March 13, 2023

Page 1 of 36

Next Page